Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
Psoralen photoproducts were identified in association with cataracts in a psoriatic patient several years after oral methoxsalen plus ultraviolet A light (PUVA) therapy. Patients should be required to wear adequate optical protection not only during PUVA therapy but 24 hours following ingestion of methoxsalen.
D000328:Adult; D002386:Cataract / Q000139:chemically induced*; D006801:Humans; D007908:Lens, Crystalline / Q000032:analysis; D008297:Male; D008730:Methoxsalen / Q000009:adverse effects*; D011701:PUVA Therapy / Q000009:adverse effects*; D010778:Photochemotherapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy*; D014466:Ultraviolet Rays / Q000009:adverse effects
D008730:Methoxsalen